• SENSEX 76,755.05
    -715.06 (--0.92%)
  • BANKNIFTY 57,126.80
    -708.55 (--1.23%)
  • Bharti Airtel
    1,956.00 2,174.70(%)
  • Bluestone Jewel
    872.60 872.60(%)
  • Anthem Bioscienc
    735.10 579.45(%)
  • IndusInd Bank
    1,077.80 1,077.80(%)
  • M & M Fin. Serv.
    384.55 412.30(%)
  • Data Pattern
    4,800.00 4,955.00(%)
  • TVS Motor Co.
    3,965.00 3,970.00(%)
  • Cummins India
    5,635.00 6,142.80(%)
  • Bajaj Auto
    11,025.00 11,025.00(%)
  • SBI Funds Mgt.
    582.55 582.55(%)
  • Bandhan Bank
    169.65 134.30(%)
  • HDFC Bank
    750.25 726.75(%)
  • Kalyan Jewellers
    601.25 617.30(%)
  • Eternal
    275.70 212.55(%)
  • Reliance Industries
    1,284.00 1,253.65(%)
  • Bajaj Finance
    1,056.30 788.40(%)
  • Dixon Technolog.
    13,650.00 9,605.05(%)
  • Himadri Special
    760.20 420.00(%)
  • Titan Company
    4,730.10 4,730.10(%)
  • Nestle India
    1,509.75 1,509.75(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Corona Remedies Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 71174.0
  • ISIN : INE02ZQ01018
2,042.70 -47 (-2.27%)
  • As on 22 Jul 2026 (EOD)

  • Today’s Low

    2,036.70

  • Today’s High

    2,104.90

  • Open

    2,090.20

  • Perv Close

    2,090.20

  • 52W Low

    1,336.60

  • 52W High

    2,128.40

Key Indicators

  • P/E(TTM)

    62.60

  • Mar.Cap (₹Cr.)

    12,493.17

  • Div & Yield %

    0.49

  • Book Value(₹)

    121.97

  • Debt-Equity Ratio

    -2.27

  • AGM Date

    22-Jul-2026

  • EPS

    32.63

  • P/E Ratio

    62.60

Financials Ratios

  • Debt-Equity Ratio

    0.21

  • Mar.Cap (₹Cr.)

    12,493.17

  • RONW (%)

    20.36

  • ROCE (%)

    23.46

Score Board

  • Equity (₹ in Cr.)

    61.16

  • BV (₹)

    122.00

  • Sales( ₹ in Cr.)

    1,403.18

  • NP (in Cr.)

    199.58

  • NP Var(%)

    33.0

  • Div%

    100.0

  • CPS (₹)

    38.80

  • EPS (₹)

    32.60

  • Traded Value (₹ in Lakhs)

    12,492.56

  • 52 Week High

    2,128.40

  • 52 Week Low

    1,336.60

  • Price BSE

    2043.0

  • Price NSE

    2,043.00

  • Market Capital( in Cr.)

    12,492.56

  • P/C Ratio

    52.60

  • P/E Ratio

    62.60

  • Price Vs.BV

    32.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,403.18 1,196.42 1,014.47 884.05 617.33 576.16
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,403.18 1,196.42 1,014.47 884.05 617.33 576.16
Other Income 10.65 5.93 6.46 7.05 6.60 4.94
Stock Adjustments -7.05 23.74 0.78 14.51 40.57 2.72
Total Income 1,406.78 1,226.09 1,021.71 905.61 664.50 583.82
EXPENDITURE :            
Raw Materials 253.89 260.26 227.61 225.46 187.21 147.19
Power and Fuel Cost 5.69 6.03 5.66 3.97 3.51 1.14
Employee Cost 403.02 346.14 295.37 254.77 226.65 176.36
Other Manufacturing Expenses 11.00 6.57 6.46 4.64 7.24 1.54
Selling and Administration Expenses 355.83 301.37 259.84 233.11 92.46 130.99
Miscellaneous Expenses 92.36 59.81 65.58 48.63 123.00 16.29
Employee Benefit Expenses 403.02 346.14 295.37 254.77 226.65 176.36
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,121.79 980.18 860.52 770.58 640.08 473.49
Operating Profit 284.99 245.91 161.20 135.03 24.42 110.33
Interest 6.97 10.60 14.44 4.27 4.73 2.01
Gross Profit 278.02 235.31 146.76 130.76 19.69 108.32
Depreciation 37.87 37.16 28.28 20.10 20.48 15.89
Profit Before Tax 240.15 198.15 118.48 110.66 -0.79 92.43
Current Tax 51.48 44.80 18.88 26.27 0.00 25.98
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 3.82 4.30 9.10 -0.32 -0.39 -3.50
Reported Net Profit 184.85 149.05 90.50 84.70 -0.40 69.95
Extraordinary Items -14.73 -0.53 -0.71 0.11 0.18 0.00
Adjusted Net Profit 199.58 149.58 91.21 84.59 -0.58 69.95
Adjustment below Net Profit 0.11 -0.87 -1.67 -0.45 0.00 -0.17
P & L Balance brought forward 502.98 377.43 305.55 228.27 236.00 166.22
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 44.71 22.63 16.94 6.97 7.33 0.00
P & L Balance carried down 643.23 502.98 377.43 305.55 228.27 236.00
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 100.00 73.10 37.00 27.70 0.00 0.00
Dividend Per Share(Rs) 10.00 7.31 3.70 2.77 0.00 0.00
Earnings Per Share-Unit Curr 30.22 24.37 14.80 13.85 -0.08 150.71
Earnings Per Share(Adj)-Unit Curr 30.22 - - - - -
Book Value 121.97 99.04 78.51 66.70 62.86 727.91
Book Value(Adj)-Unit Curr 121.97 - - - - -

Shareholding Pattern

  • Promoter Group

    69.00%

  • Public Share Holding

    31.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 42,197,968 69.00 42,197,968 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 42,197,968 69.00 42,197,968 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 2,219,305 3.63 2,219,305 37
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 176,740 0.29 176,740 2
Mutual Funds / UTI 7,646,227 12.50 7,646,227 13
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 66,343 0.11 66,343 5
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 10,108,615 16.53 10,108,615 57
2] Non Institution
Bodies Corporate 363,404 0.59 363,404 39
Clearing Members 2,126 0.00 2,126 3
Directors of their Relatives 57 0.00 57 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 5,085 0.01 5,085 91
Foreign Non Institution Other 7,755,786 12.68 7,755,786 1
Hindu Undivided Families 19,331 0.03 19,331 522
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 25,755 0.04 25,755 1
Individuals holding nominal share capital up to Rs. 1 lakh 520,475 0.85 520,475 19,461
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 161,400 0.26 161,400 1
Others 86 0.00 86 2
Sub Total 8,853,505 14.48 8,853,505 20,122
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 61,160,088 100.00 61,160,088 20,185

Company Background

Corona Remedies LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Corona Remedies Ltd
  • BSE Code : 71174.0
  • ISIN : INE02ZQ01018

  • Incorporation Year

    2004

  • Registered Office

    Corona House C-Mondeal Busines
    #NAME?, Ahmedabad,
    Gujarat-380059

  • Telephone

    +91 79 4023 3000

  • FAX

  • Chairman

    KIRTIKUMAR LAXMIDAS MEHTA

  • Managing Director

  • Company Secretary

    Chetna Darajiya

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Corona Remedies Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Corona Remedies 2,042.60 1,413.83 1,403.18 67.59 28.95
P & G Health Ltd 6,718.20 944.52 934.17 34.11 71.75
Sanofi India 3,403.50 1,857.10 1,837.40 25.30 54.17
Glaxosmi. Pharma 2,551.10 3,932.76 3,790.20 42.71 58.17
Novartis India 1,699.05 398.23 356.27 45.02 16.64
Cipla 1,415.10 20,102.60 18,979.95 32.52 13.88
Amrutanjan Healt 529.35 469.50 451.82 26.43 21.89
Bliss GVS Pharma 448.15 773.53 729.81 49.09 12.51
Fermenta Biotec. 420.85 442.21 430.53 19.27 17.61
Guj. Themis Bio. 351.75 152.47 150.80 82.18 27.21
Ambalal Sarabhai 31.49 19.52 3.94 22.02 6.77